language_icon
EN
HI

Lyka Labs Share price

LYKALABS

59.49

0.00 (0.00%)
NSE
BSE
Last updated on 22 Apr, 2026 | 15:41 IST
Today's High

59.80

Today's Low

57.25

52 Week Low

44.10

52 Week High

128.78

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Lyka Labs Chart

Lyka Labs Share Key Metrics

Volume
17899.00
Market Cap
212.32 CR
LTQ@LTP
873@59.49
ATP
58.6
Var Margin
100 %
Circuit Range
56.52-62.46
Delivery %
0 %
Value
10.49 L
ASM/GSM
No
Market Lot
1

Summary

Lyka Labs share price stands at ₹59.49 at 22 Apr, 2026 | 15:41. The stock Lyka Labs intraday movement has stayed between ₹57.25 and ₹59.80, while on a 52-week basis it has fluctuated from ₹44.10 to ₹128.78.
In terms of trading activity, Lyka Labs has recorded a volume of 17899 shares. The Lyka Labs has a market cap of ₹35690000. The stock’s Average Traded Price (ATP) stands at ₹5860, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 873, 5949.
The Lyka Labs operates within a circuit range of ₹56.52-62.46 – ₹56.52-62.46, with a Value of ₹10.49 L. The Delivery Percentage for the day is 0%. Additionally, Lyka Labs currently falls under the No framework, and trades with a market lot size of 1.

Lyka Labs Fundamentals

View More
P/E Ratio

0

P/B Ratio

2.09

Div. Yield

0

Sector P/E

63.84

Sector P/B

3.48

Sec. Div. Yield

0.57

Lyka Labs Resistance and Support

Pivot 58.85

Resistance

First Resistance

60.45

Second Resistance

61.4

Third Resistance

63

Support

First Support

57.9

Second Support

56.3

Third Support

55.35

Lyka Labs Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

58.16%

Mutual Fund

0.01%

Insurance

0.28%

Foreign Institutional Investors

0.29%

Domestic Institutional Investors

0.38%

Retail

40.88%

Others

0%

Total Promoters
MAR '26
58.16%

Lyka Labs Corporate Actions

DateAgenda
No Data Found

Lyka Labs News

Lyka Labs Limited

Lyka Labs promoters and Persons Acting in Concert declared nil pledged equity shares for FY26, fulfilling SEBI Regulation 31(4) requirements. This signifies no encumbrance on their shareholding as of March 31, 2026.
Apr 10 2026 15:04:00

Lyka Labs Limited

Ipca Laboratories, as a promoter of Lyka Labs Limited, along with other persons acting in concert, declared that they have not made any encumbrance on their equity shares for the financial year ended March 31, 2026, ensuring compliance with SEBI regulations.
Apr 09 2026 19:04:00

Lyka Labs Limited

Lyka Labs received NCLT sanction for the amalgamation of Lyka Exports with itself. The scheme became effective on April 8, 2026, leading to an increase in Lyka Labs' authorized share capital after filing with the Registrar of Companies, Ahmedabad.
Apr 09 2026 16:04:00

Lyka Labs Ltd - 500259 - Update On The Scheme Of Amalgamation

Lyka Labs' scheme of amalgamation with Lyka Exports became effective from April 8, 2026, after NCLT sanction. The company's authorized share capital increased to ₹59 crores, comprising equity and preference shares.
Apr 09 2026 16:04:00

Lyka Labs Ltd - 500259 - Clarification On Price Movement

Lyka Labs clarifies to BSE regarding the significant movement in its share price. The company states there are no material undisclosed information or events that required disclosure and bore on the price movement, confirming compliance with SEBI regulations.
Apr 09 2026 16:04:00

Lyka Labs Limited

Lyka Labs board appointed M/s. Nidhi Subhash Tibrewala & Co. as Cost Auditors for the financial years 2025-26 and 2026-27. This appointment fills the casual vacancy created by the resignation of M/s. Rajaram M Walavalkar & Co.
Mar 31 2026 13:03:00

Lyka Labs Ltd - 500259 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 31St March, 2026

Lyka Labs board appointed M/s. Nidhi Subhash Tibrewala & Co. as cost auditors for FY2025-26, replacing M/s. Rajaram M Walavalkar & Co. due to resignation. They were also re-appointed for FY2026-27, ensuring audit continuity.
Mar 31 2026 13:03:00
Read More

About Lyka Labs

NSE : 7248  
BSE : 500259  
ISIN : INE933A01014  

Lyka Labs Management

NamePosition
Babulal JainChairman
Yogesh ShahWhole Time Director
View More

Lyka Labs FAQs

The Buying Price of Lyka Labs share is 59.49 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Lyka Labs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lyka Labs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Lyka Labs shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Lyka Labs shares is 2.09. Useful to assess the stock's value relative to its book value.

To assess Lyka Labs’s valuation compare Sector P/E, P/B which are 63.84 & 3.48 with sector averages, along with growth rates and financial metrics.

The Market Cap of Lyka Labs is 212.32 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Lyka Labs share price is 128.78 & 44.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Lyka Labs belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost